{{Rsnum
|rsid=11012732
|Gene=MLLT10
|Chromosome=10
|position=21830104
|Orientation=plus
|GMAF=0.2259
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 45.1 | 44.2 | 10.6
| HCB | 97.8 | 2.2 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 42.5 | 47.9 | 9.6
| ASW | 57.9 | 31.6 | 10.5
| CHB | 97.8 | 2.2 | 0.0
| CHD | 98.2 | 1.8 | 0.0
| GIH | 59.6 | 30.3 | 10.1
| LWK | 66.1 | 28.4 | 5.5
| MEX | 67.2 | 29.3 | 3.4
| MKK | 43.9 | 47.1 | 9.0
| TSI | 37.3 | 44.1 | 18.6
| HapMapRevision=28
}}[[rs11012732]] is a SNP in the [[MLLT10]] gene on ch 10p12.31.

A study of ~1,600 patients with [[meningioma]], all of European ancestry, concluded that increased risk for the disease was associated with [[rs11012732]](G) alleles. The odds ratio was 1.46 (p = 1.9 x 10e-14). A nearby SNP, [[rs12770228]], was also linked to [[meningioma]] risk.{{PMID|21804547}}

{{on chip | Illumina Human 1M}}